微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 79.42% | -7.34% | -0.72% | 18/54 | 69.26% | 我武生物 | 95.26% | 行业排名> |
| 2024-06-30 | 80% | -8.5% | -1.33% | 15/54 | 68.54% | 西藏药业 | 95.7% | 行业排名> |
| 2024-03-31 | 81.07% | -4.64% | -5.15% | 15/54 | 69.17% | 康华生物 | 95.85% | 行业排名> |
| 2023-12-31 | 85.47% | -2.89% | -0.28% | 13/54 | 68.33% | 我武生物 | 95.26% | 行业排名> |
| 2023-09-30 | 85.71% | -2.91% | -1.96% | 13/54 | 68.07% | 我武生物 | 95.4% | 行业排名> |
| 2023-06-30 | 87.43% | -0.12% | 2.83% | 13/54 | 63.32% | 华兰疫苗 | 101.02% | 行业排名> |
| 2023-03-31 | 85.02% | -3.85% | -3.41% | 17/54 | 69.48% | 华兰疫苗 | 100.22% | 行业排名> |
| 2022-12-31 | 88.02% | -0.67% | -0.3% | 10/54 | 68.27% | 我武生物 | 95.39% | 行业排名> |
| 2022-09-30 | 88.28% | 1.1% | 0.86% | 12/54 | 71.28% | 我武生物 | 95.63% | 行业排名> |
| 2022-06-30 | 87.53% | -0.18% | -1.01% | 16/54 | 69.18% | 我武生物 | 95.75% | 行业排名> |
| 2022-03-31 | 88.42% | 1.13% | -0.22% | 16/54 | 71.63% | 华兰疫苗 | 98.39% | 行业排名> |
| 2021-12-31 | 88.61% | 2.56% | 1.48% | 13/54 | 72.33% | 百奥泰 | 95.74% | 行业排名> |
| 2021-09-30 | 87.32% | 1.19% | -0.42% | 17/54 | 73.87% | 我武生物 | 95.89% | 行业排名> |
| 2021-06-30 | 87.69% | 10.79% | 0.3% | 16/54 | 73.72% | 百奥泰 | 96.33% | 行业排名> |
| 2021-03-31 | 87.43% | 34.11% | 1.2% | 13/54 | 73.03% | 义翘神州 | 96.83% | 行业排名> |
| 2020-12-31 | 86.4% | 8.34% | 0.13% | 18/54 | 71.61% | 义翘神州 | 96.88% | 行业排名> |
| 2020-09-30 | 86.29% | 8.31% | 9.02% | 14/54 | 73.64% | 义翘神州 | 96.56% | 行业排名> |
| 2020-06-30 | 79.15% | 0.45% | 21.4% | 29/54 | 88.2% | 华兰疫苗 | 707.43% | 行业排名> |
| 2020-03-31 | 65.19% | -14.32% | -18.25% | 22/54 | 70.26% | 我武生物 | 95.6% | 行业排名> |
| 2019-12-31 | 79.75% | -0.81% | 0.1% | 26/54 | 72.44% | 我武生物 | 96.43% | 行业排名> |
| 2019-09-30 | 79.67% | -0.67% | 1.11% | 16/54 | 70.09% | 我武生物 | 96.51% | 行业排名> |
| 2019-06-30 | 78.79% | -1.56% | 3.55% | 15/54 | 69.35% | 我武生物 | 96.46% | 行业排名> |
| 2019-03-31 | 76.09% | -2.71% | -5.36% | 14/54 | 69.07% | 我武生物 | 96.44% | 行业排名> |
| 2018-12-31 | 80.39% | 18.62% | 0.24% | 20/54 | 71.54% | 康辰药业 | 95.1% | 行业排名> |
| 2018-09-30 | 80.2% | 24.66% | 0.2% | 11/54 | 67.51% | 康辰药业 | 94.98% | 行业排名> |
| 2018-06-30 | 80.04% | 29.11% | 2.35% | 11/54 | 67.2% | 康辰药业 | 94.9% | 行业排名> |
| 2018-03-31 | 78.21% | 40.06% | 15.39% | 11/54 | 65.03% | 我武生物 | 93.37% | 行业排名> |
| 2017-12-31 | 67.78% | 29.09% | 5.35% | 25/54 | -887.82% | 我武生物 | 96.35% | 行业排名> |
| 2017-09-30 | 64.33% | 43.12% | 3.77% | 13/54 | 65.93% | 我武生物 | 97% | 行业排名> |
| 2017-06-30 | 62% | 56.15% | 11.03% | 17/54 | 63.83% | 我武生物 | 96.96% | 行业排名> |
| 2017-03-31 | 55.84% | 36.74% | 6.35% | 16/54 | 65.37% | 我武生物 | 97.16% | 行业排名> |
| 2016-12-31 | 52.5% | 22.51% | 16.79% | 24/54 | 68.41% | 欧林生物 | 99.46% | 行业排名> |
| 2016-09-30 | 44.95% | 2.63% | 13.22% | 18/54 | 63.02% | 我武生物 | 95.96% | 行业排名> |
| 2016-06-30 | 39.7% | -11.27% | -2.77% | 20/54 | -3007.12% | 欧林生物 | 99.4% | 行业排名> |
| 2016-03-31 | 40.83% | 0.35% | -4.72% | 16/54 | 61.6% | 我武生物 | 95.8% | 行业排名> |
| 2015-12-31 | 42.85% | -1.26% | -2.17% | 25/54 | 65.23% | 欧林生物 | 99.33% | 行业排名> |
| 2015-09-30 | 43.8% | -0.71% | -2.11% | 17/54 | 60.32% | 我武生物 | 95.02% | 行业排名> |
| 2015-06-30 | 44.75% | -6.21% | 9.96% | 19/54 | 61.38% | 我武生物 | 94.71% | 行业排名> |
| 2015-03-31 | 40.69% | -10.55% | -6.24% | 15/54 | 57.69% | 我武生物 | 95.59% | 行业排名> |